Xycrobe Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3


  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

Xycrobe Therapeutics General Information


Provider of biotechnological services. The company uses data generated from the human microbiome to develop therapies to address the needs of patients with inflammatory skin disease.

Contact Information

Ownership Status
Financing Status
Private Equity-Backed
Primary Industry
Corporate Office
  • 3210 Merryfield Row
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xycrobe Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Xycrobe Therapeutics‘s full profile, request access.

Request a free trial

Xycrobe Therapeutics Comparisons

HQ Location
Total Raised
Post Valuation
Provider of biotechnological services. The company uses data generated from the human microbiome to develop therapies to
San Diego, CA
3 As of 2015
000000000000 00000


quip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptat
New York, NY
00 As of 0000
00000 0000-00-00
00000000000 0000


tur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
0000 000000000
Exton, PA
00 As of 0000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Xycrobe Therapeutics Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Xalud Therapeutics Venture Capital-Backed New York, NY 00 0000 00000000000 0000
Castle Creek Biosciences Venture Capital-Backed Exton, PA 00 00000 00000000000 00000
Arcutis Biotherapeutics Formerly VC-backed Westlake Village, CA 000 00.000 00000000 00.000
Epirium Bio Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
MC2 Therapeutics Corporation Horsholm, Denmark 00
You’re viewing 5 of 30 competitors. Get the full list »

Xycrobe Therapeutics Patents

Xycrobe Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2017521059-A Mechanically aligned optical element and method of manufacturing the same Pending 17-Jun-2014 0000000000 0

Xycrobe Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Xycrobe Therapeutics FAQs

  • When was Xycrobe Therapeutics founded?

    Xycrobe Therapeutics was founded in 2014.

  • Who is the founder of Xycrobe Therapeutics?

    Thomas Hitchcock Ph.D is the founder of Xycrobe Therapeutics.

  • Where is Xycrobe Therapeutics headquartered?

    Xycrobe Therapeutics is headquartered in San Diego, CA.

  • What is the size of Xycrobe Therapeutics?

    Xycrobe Therapeutics has 3 total employees.

  • What industry is Xycrobe Therapeutics in?

    Xycrobe Therapeutics’s primary industry is Biotechnology.

  • Is Xycrobe Therapeutics a private or public company?

    Xycrobe Therapeutics is a Private company.

  • What is Xycrobe Therapeutics’s current revenue?

    The current revenue for Xycrobe Therapeutics is 000000.

  • How much funding has Xycrobe Therapeutics raised over time?

    Xycrobe Therapeutics has raised $199K.

  • Who are Xycrobe Therapeutics’s competitors?

    Xalud Therapeutics, Castle Creek Biosciences, Arcutis Biotherapeutics, Epirium Bio, and MC2 Therapeutics are some of the 30 competitors of Xycrobe Therapeutics.

  • When was Xycrobe Therapeutics acquired?

    Xycrobe Therapeutics was acquired on 22-May-2019.

  • Who acquired Xycrobe Therapeutics?

    Xycrobe Therapeutics was acquired by Crown Laboratories.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »